Search

everythinglearnresearchcommunity

for

Search:↓

Home-use light devices can significantly reduce hair but are less effective on very dark skin and slower than professional devices.

Microneedling with oral collagen improves wrinkles better than microneedling alone.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

The hair treatment made hair grow faster and thicker and strengthened the hair roots.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Genetic factors could lead to personalized treatments for hair loss.

Color changes in Minoxidil hair products do not affect their effectiveness.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Different hair loss treatment ingredients work well with TrichoTech™ vehicles for 3 to 6 months, making them good for use in hair treatments.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Light can be used to stimulate ear hair cells, improving speed and consistency over previous methods.